Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: The Integrilin and Low-Dose Thrombolysis in Acute Myocardial Infarction (INTRO AMI) trial.
Journal of the American College of Cardiology.
Times cited: 112
Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.
JAMA - Journal of the American Medical Association.
Times cited: 101